The Need-to-Know on a Slow News Day: More MFN Deals Are Coming, and Why Pharma Thinks the U.S./U.K. Trade Agreement Should Be a Model
Shares:
APEX | Obesity Grabs the Headlines: Looking at a Novo Formulary Win and a New Paper on Budget Impact
Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv
It’s Beanpot championship day, sportsfans. Go Terriers. Welcome to Day Two of Trump 2.0. This is probably a good time to expound on how I’m going to approach news coming
It’s kind of a slow day today, which has me thinking ahead to the J.P. Morgan Health Care conference in January. My thoughts are swirling around a couple of things: